# Specification Quality Checklist: Encounters, Referrals, and Contextual Chat

**Purpose**: Validate Feature 010 normative specification completeness and remaining approval gates before planning.

**Created**: 2026-09-25

**Feature**: [spec.md](../spec.md)

## Content Quality

- [x] Focuses on patient/clinician value and the frozen SHIFAA boundary.
- [x] Uses the mandatory project override sections and labels policy versus verified fact versus open decisions.
- [x] Avoids unapproved implementation, production, clinical-safety, and visual-design choices.
- [x] Master §11.2 normative logical fields/nullability, transitions, per-action RLS, API request/result/RFC 9457 errors, audit/events, UI/degraded states, threats, and deterministic vectors are specified. `OPEN-TECH-002` still requires generated full OpenAPI, physical DDL/RLS, and generated clients at its registered implementation gate; clinical and formal UI approvals are separate review gates.

## Requirement Completeness

- [x] Exactly `FR-FAC-006`, `FR-CLINIC-006`, and `FR-CLINIC-007` are targeted.
- [x] PATIENT ∪ REALTIME expands to exactly 23 immutable NFR IDs.
- [x] Exactly ten existing API operation IDs appear in the sole operation inventory; no new operation is proposed.
- [x] Six canonical data areas and the four patient/clinic route groups are present.
- [x] Primary, negative, replay, concurrency, offline, reconnect, visibility, referral, attachment, Arabic/English, and accessibility scenarios are recorded.
- [x] Feature 009 predecessor state producers and its no-encounter boundary are preserved.
- [x] Hard exclusions and all eight roadmap `OPEN-*` gates are retained.
- [x] Encounter/referral transition rules and Feature 009 handoff are unambiguous under the dated `OPEN-F010-001` reconciliation.
- [x] Note visibility and referral authorization fields/action are unambiguous for synthetic engineering under `OPEN-F010-002`; Legal/DPO production lawful-basis evidence remains open.
- [x] Chat context expiry, participant removal, and patient route placement are unambiguous under `OPEN-F010-003`; the later Feature 010 functional composition approval satisfies its scoped `OPEN-UX-001` prerequisite, while `OPEN-UX-002` formal verification remains open.
- [x] The catalog attachment field has a final Feature 010 body-only reconciliation under `OPEN-F010-004`.

## Feature Readiness

- [x] Each targeted FR maps to acceptance coverage and measurable outcomes.
- [x] Success criteria state the canonical quantitative NFR targets without claiming production/device evidence.
- [x] No Feature 011, open-ended chat, prescription/safety, unauthorized note sharing, offline clinical write, attachment upload, or invented patient chat UI is authorized.
- [x] `SPEC_APPROVED` was recorded on 2026-09-26 by Yousef Osama as Product Owner / Architecture Lead for the Feature 010 specification only. QA and affected clinical domain lead review evidence remains pending and is not claimed. The later 2026-09-26 Product Owner + Acting Design Lead decision approved only Feature 010's TEST-ONLY functional `OPEN-UX-001` baseline; the separate dated Plan Gate record now grants `PLAN_APPROVED` under the approved pre-implementation operating model. This checklist grants no implementation authority.

## Notes

Validation iteration 4 on 2026-09-26 records Yousef Osama's Product Owner / Architecture Lead `SPEC_APPROVED` decision without running a Spec Kit stage. The checklist is 19/19 for specification content and the Product Owner decision; QA and affected clinical domain lead review evidence is still unrecorded, and no approval from them is inferred. Generated/physical artifacts, formal UI, legal/production and deterministic device evidence remain at their registered gates. All eight roadmap `OPEN-*` gates remain open. No plan, tasks, implementation, commit, push, or PR was started.

Governance update on 2026-09-26: the 19/19 specification checklist remains complete. Feature 010's exact TEST-ONLY functional UX baseline is now approved at manifest SHA-256 `18e4471d686990e797e8a5e370a20ceda7ea823020e3f84fdea0e03a65394310`; this later decision supersedes the earlier pending `OPEN-UX-001` statement for Feature 010 only. `OPEN-UX-002`, the seven other Feature 010 gate IDs, QA/affected clinical review evidence and the separate Plan Gate remain pending. The earlier validation history above is retained as dated evidence, not a current gate disposition.

Plan Gate update on 2026-09-26: the separate dated Feature 010 Plan Gate record grants `PLAN_APPROVED` under the approved v2.1.2 pre-implementation operating model and supersedes the prior pending-Plan-Gate statement. This does not change the 19/19 specification checklist, waive the seven later-stage gate IDs or program-wide `OPEN-UX-001`, or claim independent QA, clinical, Legal/DPO, implementation, production or release evidence. `/speckit.tasks` has not run.
